Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.

Hjorth M, Axelsson S, Rydén A, Faresjö M, Ludvigsson J, Casas R.

Clin Immunol. 2011 Jan;138(1):117-26. doi: 10.1016/j.clim.2010.10.004. Epub 2010 Nov 1.

PMID:
21044870
[PubMed - indexed for MEDLINE]
2.

Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes.

Pihl M, Akerman L, Axelsson S, Chéramy M, Hjorth M, Mallone R, Ludvigsson J, Casas R.

Clin Exp Immunol. 2013 Jun;172(3):394-402. doi: 10.1111/cei.12078.

PMID:
23600827
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65).

Axelsson S, Hjorth M, Akerman L, Ludvigsson J, Casas R.

Diabetes Metab Res Rev. 2010 Oct;26(7):559-68. doi: 10.1002/dmrr.1126.

PMID:
20830731
[PubMed - indexed for MEDLINE]
4.

Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.

Wang LH, Lin YH, Yang J, Guo W.

Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10.

PMID:
18849611
[PubMed - indexed for MEDLINE]
5.

Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.

Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.

Eur J Immunol. 2008 May;38(5):1381-90. doi: 10.1002/eji.200737590.

PMID:
18412171
[PubMed - indexed for MEDLINE]
6.

The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.

Li L, Chao QG, Ping LZ, Xue C, Xia ZY, Qian D, Shi-ang H.

Cancer Biother Radiopharm. 2009 Jun;24(3):357-67. doi: 10.1089/cbr.2008.0612.

PMID:
19538059
[PubMed - indexed for MEDLINE]
7.

GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.

Chéramy M, Skoglund C, Johansson I, Ludvigsson J, Hampe CS, Casas R.

Clin Immunol. 2010 Oct;137(1):31-40. doi: 10.1016/j.clim.2010.06.001. Epub 2010 Jun 30.

PMID:
20580618
[PubMed - indexed for MEDLINE]
8.

The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.

Boettler T, Pagni PP, Jaffe R, Cheng Y, Zerhouni P, von Herrath M.

J Autoimmun. 2013 Aug;44:40-8. doi: 10.1016/j.jaut.2013.05.002. Epub 2013 Jun 13.

PMID:
23770292
[PubMed - indexed for MEDLINE]
Free Article
9.

Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.

Ryden A, Stechova K, Durilova M, Faresjö M.

Diabetes Metab Res Rev. 2009 May;25(4):335-43. doi: 10.1002/dmrr.958.

PMID:
19382103
[PubMed - indexed for MEDLINE]
10.

GAD treatment and insulin secretion in recent-onset type 1 diabetes.

Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R.

N Engl J Med. 2008 Oct 30;359(18):1909-20. doi: 10.1056/NEJMoa0804328. Epub 2008 Oct 8.

PMID:
18843118
[PubMed - indexed for MEDLINE]
Free Article
11.

Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.

J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15.

PMID:
20843956
[PubMed - indexed for MEDLINE]
Free Article
12.

Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes.

Axelsson S, Chéramy M, Hjorth M, Pihl M, Akerman L, Martinuzzi E, Mallone R, Ludvigsson J, Casas R.

PLoS One. 2011;6(12):e29008. doi: 10.1371/journal.pone.0029008. Epub 2011 Dec 12.

PMID:
22174945
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.

PMID:
17317763
[PubMed - indexed for MEDLINE]
Free Article
14.

Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.

PMID:
19155973
[PubMed - indexed for MEDLINE]
15.

Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.

Stroopinsky D, Avivi I, Rowe JM, Avigan D, Katz T.

Eur J Immunol. 2009 Oct;39(10):2703-15. doi: 10.1002/eji.200839097.

PMID:
19634189
[PubMed - indexed for MEDLINE]
16.

Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?

Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.

Gene Ther. 2004 Oct;11(20):1487-96.

PMID:
15343360
[PubMed - indexed for MEDLINE]
17.

Decreased GAD(65)-specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum.

Axelsson S, Hjorth M, Ludvigsson J, Casas R.

Diabet Med. 2012 Oct;29(10):1272-8. doi: 10.1111/j.1464-5491.2012.03710.x.

PMID:
22587593
[PubMed - indexed for MEDLINE]
18.

Higher FoxP3 mRNA expression in peripheral blood mononuclear cells of GAD65 or IA-2 autoantibody-positive compared with autoantibody-negative persons.

Link M, Salur L, Kisand K, Rajasalu T, Tillmann V, Uibo R.

APMIS. 2008 Oct;116(10):896-902. doi: 10.1111/j.1600-0463.2008.00889.x.

PMID:
19132983
[PubMed - indexed for MEDLINE]
19.

A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.

Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54.

PMID:
17671115
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk